OC
ACH

Oppenheimer & Co’s Accendra Health ACH Stock Holding History

Oppenheimer & Co’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-13,000
Closed -$82K – 1375
2018
Q4 		$82K Sell
13,000
-16,000
-55% -$166K ﹤0.01% 1195
2018
Q3 		$480K Buy
29,000
+2,000
+7% +$34K 0.01% 881
2018
Q2 		$451K Hold
27,000
– – 0.01% 907
2018
Q1 		$420K Buy
+27,000
New +$481K 0.01% 912
2017
Q4 		– Sell
-9,376
Closed -$274K – 1344
2017
Q3 		$274K Buy
9,376
+2,816
+43% +$83.2K 0.01% 1065
2017
Q2 		$211K Sell
6,560
-31
-0.5% -$1.02K 0.01% 1164
2017
Q1 		$228K Sell
6,591
-1,072
-14% -$38.3K 0.01% 1110
2016
Q4 		$271K Buy
7,663
+330
+5% +$11.2K 0.01% 1040
2016
Q3 		$254K Buy
7,333
+870
+13% +$30.5K 0.01% 1049
2016
Q2 		$242K Buy
6,463
+567
+10% +$21.3K 0.01% 1037
2016
Q1 		$238K Buy
5,896
+9
+0.2% +$335 0.01% 1034
2015
Q4 		$212K Buy
+5,887
New +$213K 0.01% 1107
2015
Q3 		– Sell
-5,976
Closed -$203K – 1429
2015
Q2 		$203K Buy
5,976
+14
+0.2% +$472 0.01% 1295
2015
Q1 		$202K Buy
+5,962
New +$208K 0.01% 1303

Other funds holding ACH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Oppenheimer & Co's ACH Position: Q1 2019 in Review

Oppenheimer & Co sold out of Accendra Health (ACH) in Q1 2019, closing a stake of 13,000 shares — an estimated $82K sold.

Oppenheimer & Co first reported a position in ACH in Q1 2015 and held it in 14 quarters. The position peaked at $480K in Q3 2018. 187 funds tracked by Wall St. Rank hold ACH as of Q1 2019.

  • Oppenheimer & Co reported no remaining Accendra Health position as of Q1 2019 after selling out during the quarter.
  • Oppenheimer & Co sold 13,000 Accendra Health shares in Q1 2019, an estimated $82K.
  • Oppenheimer & Co first reported a position in Accendra Health in Q1 2015 and held it in 14 quarters.
  • Oppenheimer & Co's Accendra Health position peaked at $480K in Q3 2018.
  • 187 funds tracked by Wall St. Rank held Accendra Health as of Q1 2019.

Based on Oppenheimer & Co's 13F filing for Q1 2019, filed 24 Apr 2019.